Update date
28 Feb 2026
Shareable Research Card
MDNC - Medinotec Inc. Return On Equity
This metric view shows MDNC - Medinotec Inc. return on equity history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: 2025
- Latest reported value
- 27%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 28 Feb 2026
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: 2025.
- Latest reported value on this page: 27%.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Return On Equity
Latest reported return on equity: 27%. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
2025
SEC-backed company facts were refreshed from filings filed on 28 May 2026.
Benchmark Context
How Return On Equity compares with peers
Medinotec Inc. is outside the visible top 120 companies for return on equity in the current sample.
Compared with
Compared with 120 companies reporting return on equity in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Return On Equity is down about 71% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2015 to 31 Mar 2026.
- Nearby companies in this sample: Savara Inc and Moleculin Biotech, Inc..
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Medinotec Inc.: Return On Equity
Latest period: 2025. Period end: 28 Feb 2026. Units: %. Frequency: annual and quarterly.
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Metric Snapshot
- Latest value
- 27%
- Coverage range
- 30 Nov 2022 - 28 Feb 2026
- Fact rows
- 16
What This Metric Tells You
- Shows the reported level of return on equity over 30 Nov 2022 - 28 Feb 2026.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 16 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use annual sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Savara Inc (svra) | 58391% | Quarter - 31 Mar 2026 | Open Savara Inc Return On Equity |
| 2 | Moleculin Biotech, Inc. (mbrx) | 51267% | Quarter - 31 Mar 2026 | Open Moleculin Biotech, Inc. Return On Equity |
| 3 | Bionik Laboratories Corp. | 46191% | Quarter - 31 Mar 2023 | Open Bionik Laboratories Corp. Return On Equity |
| 4 | Athenex, Inc. | 25553% | Year - 31 Dec 2022 | Open Athenex, Inc. Return On Equity |
| 5 | Corvex, Inc. (move) | 24059% | Year - 31 Dec 2025 | Open Corvex, Inc. Return On Equity |
| 6 | Wenyuan Group Corp. (wygc) | 21298% | Year - 31 Dec 2025 | Open Wenyuan Group Corp. Return On Equity |
Metric Details
- Metric
- Return On Equity (ROE)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- annual and quarterly
- History range
- 30 Nov 2022 - 28 Feb 2026
- Facts on this page
- 16
- Metric definition
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Metric-level SEC endpoint
- Open SEC company concept
Metric identity
Metric coverage
How to read it
SEC evidence
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Medinotec Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | 27% | -65% | -71% | 01 Mar 2025 | 28 Feb 2026 |
| 2024 | 92% | +106% | 01 Mar 2024 | 28 Feb 2025 | |
| 2023 | -15% | 01 Mar 2023 | 29 Feb 2024 |
Medinotec Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | 49% | +17% | +54% | 01 Sep 2025 | 30 Nov 2025 |
| Q3 2025 | 55% | +56% | 01 Jun 2025 | 31 Aug 2025 | |
| Q2 2025 | 62% | +77% | 01 Mar 2025 | 31 May 2025 | |
| Q1 2025 | 73% | +90% | 01 Dec 2024 | 28 Feb 2025 | |
| Q4 2024 | 32% | +61% | 01 Sep 2024 | 30 Nov 2024 | |
| Q3 2024 | -0.97% | +8.9% | +90% | 01 Jun 2024 | 31 Aug 2024 |
| Q2 2024 | -15% | -5% | -51% | 01 Mar 2024 | 31 May 2024 |
| Q1 2024 | -17% | -4.2% | -33% | 01 Dec 2023 | 29 Feb 2024 |
| Q4 2023 | -29% | 01 Sep 2023 | 30 Nov 2023 | ||
| Q3 2023 | -9.9% | 01 Jun 2023 | 31 Aug 2023 | ||
| Q2 2023 | -10% | 01 Mar 2023 | 31 May 2023 | ||
| Q1 2023 | -13% | 01 Dec 2022 | 28 Feb 2023 | ||
| Q4 2022 | -1.4% | 01 Sep 2022 | 30 Nov 2022 |
* indicates a reported value that failed the local validity check.